BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 29210118)

  • 21. Parthenolide Covalently Targets and Inhibits Focal Adhesion Kinase in Breast Cancer Cells.
    Berdan CA; Ho R; Lehtola HS; To M; Hu X; Huffman TR; Petri Y; Altobelli CR; Demeulenaere SG; Olzmann JA; Maimone TJ; Nomura DK
    Cell Chem Biol; 2019 Jul; 26(7):1027-1035.e22. PubMed ID: 31080076
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Tavares WR; Seca AML
    Antioxidants (Basel); 2019 May; 8(5):. PubMed ID: 31064136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alantolactone promotes ER stress-mediated apoptosis by inhibition of TrxR1 in triple-negative breast cancer cell lines and in a mouse model.
    Yin C; Dai X; Huang X; Zhu W; Chen X; Zhou Q; Wang C; Zhao C; Zou P; Liang G; Rajamanickam V; Wang O; Zhang X; Cui R
    J Cell Mol Med; 2019 Mar; 23(3):2194-2206. PubMed ID: 30609207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platycodin D inhibits tumor growth by antiangiogenic activity via blocking VEGFR2-mediated signaling pathway.
    Luan X; Gao YG; Guan YY; Xu JR; Lu Q; Zhao M; Liu YR; Liu HJ; Fang C; Chen HZ
    Toxicol Appl Pharmacol; 2014 Nov; 281(1):118-24. PubMed ID: 25250884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alantolactone selectively suppresses STAT3 activation and exhibits potent anticancer activity in MDA-MB-231 cells.
    Chun J; Li RJ; Cheng MS; Kim YS
    Cancer Lett; 2015 Feb; 357(1):393-403. PubMed ID: 25434800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raddeanin A, a triterpenoid saponin isolated from Anemone raddeana, suppresses the angiogenesis and growth of human colorectal tumor by inhibiting VEGFR2 signaling.
    Guan YY; Liu HJ; Luan X; Xu JR; Lu Q; Liu YR; Gao YG; Zhao M; Chen HZ; Fang C
    Phytomedicine; 2015 Jan; 22(1):103-10. PubMed ID: 25636878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sesquiterpene lactones-enriched fraction of Inula helenium L. induces apoptosis through inhibition of signal transducers and activators of transcription 3 signaling pathway in MDA-MB-231 breast cancer cells.
    Chun J; Song K; Kim YS
    Phytother Res; 2018 Dec; 32(12):2501-2509. PubMed ID: 30251272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alantolactone, a sesquiterpene lactone, inhibits breast cancer growth by antiangiogenic activity via blocking VEGFR2 signaling.
    Liu YR; Cai QY; Gao YG; Luan X; Guan YY; Lu Q; Sun P; Zhao M; Fang C
    Phytother Res; 2018 Apr; 32(4):643-650. PubMed ID: 29210118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alantolactone: A sesquiterpene lactone with diverse pharmacological effects.
    Liu X; Bian L; Duan X; Zhuang X; Sui Y; Yang L
    Chem Biol Drug Des; 2021 Dec; 98(6):1131-1145. PubMed ID: 34624172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting apoptosis pathways in cancer with alantolactone and isoalantolactone.
    Rasul A; Khan M; Ali M; Li J; Li X
    ScientificWorldJournal; 2013; 2013():248532. PubMed ID: 24288468
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comprehensive review of anticancer mechanisms of action of Alantolactone.
    Babaei G; Gholizadeh-Ghaleh Aziz S; Rajabi Bazl M; Khadem Ansari MH
    Biomed Pharmacother; 2021 Apr; 136():111231. PubMed ID: 33454597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alantolactone: A Natural Plant Extract as a Potential Therapeutic Agent for Cancer.
    Cai Y; Gao K; Peng B; Xu Z; Peng J; Li J; Chen X; Zeng S; Hu K; Yan Y
    Front Pharmacol; 2021; 12():781033. PubMed ID: 34899346
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.